Evrima is a clinical trial recruitment platform that connects all stakeholders to create a transparent and streamlined clinical trial experience for everyone.
Problem
- Costly and inefficient recruitment: Patient recruitment for clinical trials is a $7.6 billion dollar problem, plagued by high costs and manual processes.
- Low participation rates: There is low patient, with only 0.2% of doctors referring patients to trials.
- Extended timelines: Difficulties in recruiting patients contribute to delay in drug and therapeutic development, with an estimated 80% of clinical trials being delayed.
Solution
- Expanding patient pool: Evrima addresses the recruitment problem by significantly widening the pool of relevant patients and precisely identifying potential candidates.
- Integration with GP clinics: By integrating with GPs clinics–often the first point of contact for patients–Evrima can easily match trial requirements with highly relevant candidates using electronic health records.
- Reducing referral barriers: This integration also lowers the barrier for GPs to refer patients, tapping into 99% of the patient pool that is typically inaccessible through traditional untargeted methods.
Media Links
Type
Healthcare
Focus Area
Enterprise and Sustainability
Capital Raised (US$)
1M to 5M
Operational HQ
Australia
SECTOR
Automation, Database Management Systems, Enterprise Data & Software, and MedTech
status
Current
founders
Charlotte Bradshaw
partnered
2021
exited
You may be interested in...
